Dapwiz (5mg) 10 Tablets
Dapagliflozin 5mg tablets for type 2 diabetes.
Dapwiz (5mg) contains dapagliflozin, an SGLT2 inhibitor for type 2 diabetes. It increases urinary glucose excretion. Used as monotherapy or in combination with other antidiabetic agents. Take once daily in the morning as directed.
Purpose
Treatment of type 2 diabetes mellitus as monotherapy or in combination with other antidiabetic agents.
Ingredients
Dapagliflozin 5mg per tablet.
Warnings
Contraindicated in severe renal impairment and diabetic ketoacidosis. Not for type 1 diabetes. Risk of genital and urinary infections.
Side Effects
Urinary tract infections, genital mycotic infections, volume depletion, nausea. Rare: ketoacidosis. Report unusual tiredness or abdominal pain.
Storage Instructions
Store below 30°C in a dry place. Keep in original pack; protect from moisture.
| Brand | Pharmevo |
| Status | Active |
Related Products
